INDO US BIOTECH
Back to Cashflow Statement
|
INDO US BIOTECH Last 5 Year Net Cash Inflow / Outflow History
[Standalone]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Net Cash Inflow / Outflow | ₹-0.85 Cr | ₹0.91 Cr | ₹0.14 Cr | ₹-0.08 Cr | ₹-0.07 Cr |
What is the latest Net Cash Inflow / Outflow ratio of INDO US BIOTECH ?
Year | Net Cash Inflow / Outflow |
---|---|
Mar2025 | ₹-0.85 Cr |
Mar2024 | ₹0.91 Cr |
Mar2023 | ₹0.14 Cr |
Mar2022 | ₹-0.08 Cr |
Mar2021 | ₹-0.07 Cr |
How is Net Cash Inflow / Outflow of INDO US BIOTECH Trending?
Years | Net Cash Inflow / Outflow | % Change | |
---|---|---|---|
Mar2025 | ₹-0.85 Cr | Negative | |
Mar2024 | ₹0.91 Cr | 544.68 | |
Mar2023 | ₹0.14 Cr | Positive | |
Mar2022 | ₹-0.08 Cr | Negative | |
Mar2021 | ₹-0.07 Cr | - |
Compare Net Cash Inflow / Outflow of peers of INDO US BIOTECH
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
INDO US BIOTECH | ₹288.7 Cr | -0.4% | -5.2% | -56.8% | Stock Analytics | |
BOMBAY BURMAH TRADING CORPORATION | ₹13,507.8 Cr | -1.2% | 3.7% | -28.8% | Stock Analytics | |
KAVERI SEED COMPANY | ₹6,090.6 Cr | 2.8% | 8.9% | 9.7% | Stock Analytics | |
VENKYS (INDIA) | ₹2,143.8 Cr | 1.7% | 6.9% | -33.4% | Stock Analytics | |
BOMBAY SUPER HYBRID SEEDS | ₹1,365.6 Cr | -3.8% | -2.4% | -30.1% | Stock Analytics | |
MANGALAM GLOBAL ENTERPRISE | ₹513.1 Cr | 3.9% | -3.4% | NA | Stock Analytics |
INDO US BIOTECH Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
INDO US BIOTECH | -0.4% |
-5.2% |
-56.8% |
SENSEX | 0.9% |
1.2% |
-0.4% |
You may also like the below Video Courses